Dr. Zhou Xinhua, President, Chief Scientist, Genor Biopharma Co. Ltd. 

Dr. Zhou Xinhua is currently the President and Chief Scientist of Genor BiopharmaCo., Ltd. In 1990, he received his PhD from the School of Pharmacy, Queen’s UniversityBelfast, UK and carried on his postdoctoral research in the Department of Biochemistry, Birmingham University, UK and the Department of Chemistry, Oklahoma University, USA.

He was the Director of Process Development Science at Amgen, the world's largest biopharmaceutical company. Afterward, he became avisiting professor appointed by Amgen and engaged as an IPEM project in Peking University for ten years. Because of his discovery and leadership in the molecular mechanism of photooxidation yellowing of monoclonal antibodies, he was awarded the AMGEN Prize for Advancement in Science and Engineering in 2007.

Dr. Zhou has compiled two books, deliveredmore than 150 domestic and international address, and published more than 60 papers, 18 patents and more than 10 book chapters. Dr. Zhou is the initiator and first chairman of CPQA and ISPE China Biopharmaceuticals, as well as the first chairman of Amgen's Chinese Alumni Association. Since 2013, he has participated as a national talent pool reviewer in the evaluation of national and provincial talents, teams and projects.